{"id":"https://openalex.org/W2053684366","doi":"https://doi.org/10.1097/00003246-199905000-00025","title":"An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shock","display_name":"An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shock","alternate_titles":[],"publication_year":1999,"publication_date":"1999-05-01","ids":{"openalex":"https://openalex.org/W2053684366","doi":"https://doi.org/10.1097/00003246-199905000-00025","mag":"2053684366","pmid":"https://pubmed.ncbi.nlm.nih.gov/10362413"},"language":"en","primary_location":{"id":"doi:10.1097/00003246-199905000-00025","doi":"https://doi.org/10.1097/00003246-199905000-00025","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00003246-199905000-00025","pdf_url":null,"source":{"id":"https://openalex.org/S108732581","display_name":"Critical Care Medicine","issn_l":"0090-3493","issn":["0090-3493","1530-0293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Care Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2053684366"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Robert Grover","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Robert Grover","raw_affiliation_strings":["International Department of Cardiovascular/Critical Care Medicine Clinical Research, Glaxo Wellcome Research and Development, Greenford, UK","Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","On behalf of the Glaxo Wellcome International Septic Shock Study Group","Sponsored and supported, in part, by Glaxo Wellcome plc","The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Department of Cardiovascular/Critical Care Medicine Clinical Research, Glaxo Wellcome Research and Development, Greenford, UK","institution_ids":[]},{"raw_affiliation_string":"Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","institution_ids":[]},{"raw_affiliation_string":"On behalf of the Glaxo Wellcome International Septic Shock Study Group","institution_ids":[]},{"raw_affiliation_string":"Sponsored and supported, in part, by Glaxo Wellcome plc","institution_ids":[]},{"raw_affiliation_string":"The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090128262","display_name":"David Zaccardelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Zaccardelli","raw_affiliation_strings":["Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","On behalf of the Glaxo Wellcome International Septic Shock Study Group","Sponsored and supported, in part, by Glaxo Wellcome plc","The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","institution_ids":[]},{"raw_affiliation_string":"On behalf of the Glaxo Wellcome International Septic Shock Study Group","institution_ids":[]},{"raw_affiliation_string":"Sponsored and supported, in part, by Glaxo Wellcome plc","institution_ids":[]},{"raw_affiliation_string":"The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068913631","display_name":"Gene Colice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799301129","display_name":"Ben Taub Hospital","ror":"https://ror.org/042ze4p12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799301129","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I2802054198","display_name":"Erasmus Hospital","ror":"https://ror.org/05j1gs298","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2802054198"]},{"id":"https://openalex.org/I4210098291","display_name":"Homerton University Hospital","ror":"https://ror.org/00x444s43","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210098291","https://openalex.org/I4210112187"]},{"id":"https://openalex.org/I4210112187","display_name":"Homerton University Hospital NHS Foundation Trust","ror":"https://ror.org/01zpp3d44","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210112187"]}],"countries":["BE","GB","US"],"is_corresponding":false,"raw_author_name":"Gene Colice","raw_affiliation_strings":["Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","On behalf of the Glaxo Wellcome International Septic Shock Study Group","Sponsored and supported, in part, by Glaxo Wellcome plc","The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece","the Department of Intensive Care (Dr. Watson), Homerton Hospital, London, UK","the Department of Intensive Care (Professor Vincent), Erasme Hospital, Brussels, Belgium","the Department of Medical Intensive Care (Dr. Guntupalli), Ben Taub General Hospital, Houston, TX","the International Department of Cardiovascular/Critical Care Medicine Clinical Research (Drs. Grover, Zaccardelli, Colice), and Glaxo Wellcome Research and Development, Greenford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","institution_ids":[]},{"raw_affiliation_string":"On behalf of the Glaxo Wellcome International Septic Shock Study Group","institution_ids":[]},{"raw_affiliation_string":"Sponsored and supported, in part, by Glaxo Wellcome plc","institution_ids":[]},{"raw_affiliation_string":"The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece","institution_ids":[]},{"raw_affiliation_string":"the Department of Intensive Care (Dr. Watson), Homerton Hospital, London, UK","institution_ids":["https://openalex.org/I4210098291","https://openalex.org/I4210112187"]},{"raw_affiliation_string":"the Department of Intensive Care (Professor Vincent), Erasme Hospital, Brussels, Belgium","institution_ids":["https://openalex.org/I2802054198"]},{"raw_affiliation_string":"the Department of Medical Intensive Care (Dr. Guntupalli), Ben Taub General Hospital, Houston, TX","institution_ids":["https://openalex.org/I2799301129"]},{"raw_affiliation_string":"the International Department of Cardiovascular/Critical Care Medicine Clinical Research (Drs. Grover, Zaccardelli, Colice), and Glaxo Wellcome Research and Development, Greenford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108386653","display_name":"Kalpalatha K. Guntupalli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kalpalatha Guntupalli","raw_affiliation_strings":["Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","On behalf of the Glaxo Wellcome International Septic Shock Study Group","Sponsored and supported, in part, by Glaxo Wellcome plc","The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","institution_ids":[]},{"raw_affiliation_string":"On behalf of the Glaxo Wellcome International Septic Shock Study Group","institution_ids":[]},{"raw_affiliation_string":"Sponsored and supported, in part, by Glaxo Wellcome plc","institution_ids":[]},{"raw_affiliation_string":"The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002993982","display_name":"David Ian Watson","orcid":"https://orcid.org/0000-0002-7683-2693","observed_orcids":["https://orcid.org/0000-0002-7683-2693"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Watson","raw_affiliation_strings":["Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","On behalf of the Glaxo Wellcome International Septic Shock Study Group","Sponsored and supported, in part, by Glaxo Wellcome plc","The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","institution_ids":[]},{"raw_affiliation_string":"On behalf of the Glaxo Wellcome International Septic Shock Study Group","institution_ids":[]},{"raw_affiliation_string":"Sponsored and supported, in part, by Glaxo Wellcome plc","institution_ids":[]},{"raw_affiliation_string":"The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003379719","display_name":"Jean\u2010Louis Vincent","orcid":"https://orcid.org/0000-0001-6011-6951","observed_orcids":["https://orcid.org/0000-0001-6011-6951"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Louis Vincent","raw_affiliation_strings":["Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","On behalf of the Glaxo Wellcome International Septic Shock Study Group","Sponsored and supported, in part, by Glaxo Wellcome plc","The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. R. Grover, Glaxo Wellcome Research and Development, Building 2, Greenford Road, Greenford, Middlesex, UB6 0HE, UK","institution_ids":[]},{"raw_affiliation_string":"On behalf of the Glaxo Wellcome International Septic Shock Study Group","institution_ids":[]},{"raw_affiliation_string":"Sponsored and supported, in part, by Glaxo Wellcome plc","institution_ids":[]},{"raw_affiliation_string":"The data from this study were presented, in part, at the 8th Annual Congress of the European Society of Intensive Care Medicine, October 18-22, 1995, Athens, Greece","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":19.3895,"has_fulltext":false,"cited_by_count":206,"citation_normalized_percentile":{"value":0.99544602,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"27","issue":"5","first_page":"913","last_page":"922"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11700","display_name":"Hemodynamic Monitoring and Therapy","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/septic-shock","display_name":"septic shock","score":0.7760000228881836},{"id":"https://openalex.org/keywords/nitric-oxide-synthase-inhibitors","display_name":"nitric oxide synthase inhibitors","score":0.8769999742507935},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7310000061988831},{"id":"https://openalex.org/keywords/vascular-tone","display_name":"vascular tone","score":0.7829999923706055},{"id":"https://openalex.org/keywords/mean-arterial-pressure","display_name":"mean arterial pressure","score":0.8669999837875366},{"id":"https://openalex.org/keywords/systemic-vascular-resistance","display_name":"systemic vascular resistance","score":0.9290000200271606},{"id":"https://openalex.org/keywords/oxygen-delivery","display_name":"oxygen delivery","score":0.7559999823570251},{"id":"https://openalex.org/keywords/oxygen-extraction","display_name":"oxygen extraction","score":0.7440000176429749},{"id":"https://openalex.org/keywords/venous-admixture","display_name":"venous admixture","score":0.8700000047683716},{"id":"https://openalex.org/keywords/hemodynamics","display_name":"hemodynamics","score":0.6389999985694885},{"id":"https://openalex.org/keywords/plasma-nitrate","display_name":"plasma nitrate","score":0.7419999837875366},{"id":"https://openalex.org/keywords/vasoactive-therapy","display_name":"vasoactive therapy","score":0.6079999804496765},{"id":"https://openalex.org/keywords/critical-care","display_name":"intensive care","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C2777628635","wikidata":"https://www.wikidata.org/wiki/Q1765564","display_name":"Septic shock","level":3,"score":0.8813431262969971},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8668609857559204},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.6164748072624207},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5750900506973267},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5482228398323059},{"id":"https://openalex.org/C2776452961","wikidata":"https://www.wikidata.org/wiki/Q1940733","display_name":"Mean arterial pressure","level":4,"score":0.5396943092346191},{"id":"https://openalex.org/C58245268","wikidata":"https://www.wikidata.org/wiki/Q456026","display_name":"Vascular resistance","level":3,"score":0.5200259685516357},{"id":"https://openalex.org/C178853913","wikidata":"https://www.wikidata.org/wiki/Q1642137","display_name":"Hemodynamics","level":2,"score":0.5021646022796631},{"id":"https://openalex.org/C31861589","wikidata":"https://www.wikidata.org/wiki/Q618068","display_name":"Cardiac index","level":4,"score":0.47273528575897217},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4711172580718994},{"id":"https://openalex.org/C2781300812","wikidata":"https://www.wikidata.org/wiki/Q178061","display_name":"Shock (circulatory)","level":2,"score":0.4610212743282318},{"id":"https://openalex.org/C2781185063","wikidata":"https://www.wikidata.org/wiki/Q422782","display_name":"Dobutamine","level":3,"score":0.46032655239105225},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.44545885920524597},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.41434192657470703},{"id":"https://openalex.org/C2778384902","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Sepsis","level":2,"score":0.40810489654541016},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.33280616998672485},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31312042474746704},{"id":"https://openalex.org/C139940330","wikidata":"https://www.wikidata.org/wiki/Q596579","display_name":"Cardiac output","level":3,"score":0.2938489317893982},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001784","descriptor_name":"Blood Gas Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010101","descriptor_name":"Oxygen Consumption","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014662","descriptor_name":"Vasoconstrictor Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019001","descriptor_name":"Nitric Oxide Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1097/00003246-199905000-00025","doi":"https://doi.org/10.1097/00003246-199905000-00025","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00003246-199905000-00025","pdf_url":null,"source":{"id":"https://openalex.org/S108732581","display_name":"Critical Care Medicine","issn_l":"0090-3493","issn":["0090-3493","1530-0293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Care Medicine","raw_type":"journal-article"},{"id":"pmid:10362413","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10362413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical care medicine","raw_type":"Clinical Trial"},{"id":"pmh:oai:archive.ugent.be:114502","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1854/LU-114502","pdf_url":null,"source":{"id":"https://openalex.org/S4306400478","display_name":"Ghent University Academic Bibliography (Ghent University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32597200","host_organization_name":"Ghent University","host_organization_lineage":["https://openalex.org/I32597200"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 0090-3493","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/80685","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/80685","pdf_url":null,"source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Critical care medicine, 27 (5","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1822099413","https://openalex.org/W1845860766","https://openalex.org/W1966455032","https://openalex.org/W1969850821","https://openalex.org/W1971330063","https://openalex.org/W1992983801","https://openalex.org/W2001029771","https://openalex.org/W2004570632","https://openalex.org/W2008293086","https://openalex.org/W2010489806","https://openalex.org/W2018205667","https://openalex.org/W2019951936","https://openalex.org/W2025586271","https://openalex.org/W2026038000","https://openalex.org/W2029583951","https://openalex.org/W2034797939","https://openalex.org/W2035392715","https://openalex.org/W2039602526","https://openalex.org/W2043384239","https://openalex.org/W2048635427","https://openalex.org/W2055289119","https://openalex.org/W2057979643","https://openalex.org/W2058793150","https://openalex.org/W2062454209","https://openalex.org/W2067338751","https://openalex.org/W2069884026","https://openalex.org/W2072284181","https://openalex.org/W2081759103","https://openalex.org/W2084327878","https://openalex.org/W2089537781","https://openalex.org/W2094309129","https://openalex.org/W2114563054","https://openalex.org/W2115929723","https://openalex.org/W2125642970","https://openalex.org/W2128349740","https://openalex.org/W2128855592","https://openalex.org/W2153889396","https://openalex.org/W2233900733","https://openalex.org/W2254066069","https://openalex.org/W2313326603","https://openalex.org/W2325491525","https://openalex.org/W2399194680","https://openalex.org/W2407737746","https://openalex.org/W2418902421","https://openalex.org/W4237524633","https://openalex.org/W4249401890","https://openalex.org/W4298273896"],"related_works":["https://openalex.org/W2058622617","https://openalex.org/W2038277547","https://openalex.org/W2621340832","https://openalex.org/W2029583951","https://openalex.org/W2121391159","https://openalex.org/W2036520945","https://openalex.org/W1978757347","https://openalex.org/W1993180257","https://openalex.org/W2115929723"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"assess":[2],"the":[3,6,20,52,167,196,228,242,267,275,288],"effects":[4],"of":[5,22,31,72,151,166,199,209,212,230,238,245,277,299],"nitric":[7,268],"oxide":[8,269],"synthase":[9,270],"inhibitor,":[10,271],"546C88,":[11,272],"in":[12,49,171,186,192,216,224,293],"patients":[13,57,294],"with":[14,58,207,221,251,266,295],"septic":[15,59,296],"shock":[16,60],"and":[17,51,124,140,145,189,284],"to":[18,102,110,119,130,157,163,304],"evaluate":[19],"range":[21,41],"dose":[23,40,70,169],"rates":[24],"that":[25],"sustain":[26],"mean":[27],"arterial":[28],"pressure":[29,283],"(MAP)":[30],">":[32],"or":[33,91,254,261,286],"=70":[34],"mmHg.":[35],"DESIGN:":[36],"Multicenter,":[37],"open-label,":[38],"uncontrolled,":[39],"finding":[42],"study.":[43],"SETTING:":[44],"Ten":[45],"intensive":[46],"care":[47],"units":[48],"Europe":[50],"United":[53],"States.":[54],"PATIENTS:":[55],"Thirty-two":[56],"diagnosed":[61],"within":[62,195,241],"<24":[63],"hrs.":[64,104],"INTERVENTIONS:":[65],"Patients":[66],"received":[67],"a":[68,161,190,235,306],"fixed":[69],"rate":[71,170],"546C88":[73,115,152,247,300],"at":[74,178],"either":[75],"1(n":[76],"=":[77,81,85,89,95],"6),":[78,82],"2.5":[79],"(n":[80,84,88,94],"5":[83],"4),":[86],"10":[87],"5),":[90],"20":[92],"mg/kg/hr":[93],"11)":[96],"by":[97],"intravenous":[98],"infusion":[99],"for":[100,155,290],"up":[101,156],"8":[103,158],"Conventional":[105],"vasoactive":[106],"therapy":[107,292],"was":[108,118,176,183,219,234,248],"restricted":[109],"norepinephrine":[111,168,291],"and/or":[112],"dobutamine.":[113],"During":[114],"therapy,":[116],"MAP":[117,175],"be":[120],"maintained":[121],"between":[122],"70":[123],"90":[125],"mm":[126,180],"Hg,":[127],"while":[128,174],"attempting":[129],"withdraw":[131],"any":[132,252],"concurrent":[133],"norepinephrine.":[134,213],"MEASUREMENTS":[135],"AND":[136],"MAIN":[137],"RESULTS:":[138],"Systemic":[139,201],"pulmonary":[141],"hemodynamics,":[142],"blood":[143,282],"gases,":[144],"plasma":[146],"nitrate":[147],"were":[148],"assessed.":[149],"Infusion":[150,298],"(1-20":[153,301],"mg/kg/hr)":[154,302],"hrs":[159],"enabled":[160],"60":[162],"80%":[164],"reduction":[165,208,237],"all":[172],"cohorts,":[173],"sustained":[177,236],">70":[179],"Hg.":[181],"There":[182,233],"an":[184,222],"increase":[185,223],"vascular":[187,202],"tone":[188],"decrease":[191],"cardiac":[193],"index":[194],"1st":[197,243],"hr":[198,244],"therapy.":[200,246],"resistance":[203],"returned":[204],"toward":[205],"baseline":[206],"concomitant":[210],"administration":[211],"The":[214],"decline":[215],"oxygen":[217,231],"delivery":[218],"associated":[220,250],"extraction":[225],"and,":[226],"therefore,":[227],"maintenance":[229],"consumption.":[232],"venous":[239],"admixture":[240],"not":[249],"major":[253],"dose-dependent":[255],"adverse":[256],"effect":[257],"on":[258],"pulmonary,":[259],"hepatic,":[260],"renal":[262],"function.":[263],"CONCLUSIONS:":[264],"Treatment":[265],"can":[273],"restore":[274],"balance":[276],"vasomotor":[278],"tone,":[279],"thereby,":[280],"maintaining":[281],"reducing":[285],"eliminating":[287],"requirement":[289],"shock.":[297],"appears":[303],"have":[305],"satisfactory":[307],"overall":[308],"safety":[309],"profile.":[310]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2053684366","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
